Summit Therapeutics PLC Sponsored ADR Stock
Summit Therapeutics PLC Sponsored ADR Stock price
Key metrics
| Market capitalization | $13.64b |
| Enterprise Value | $13.23b |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 35.08 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-211.29m |
| Free Cash Flow (TTM) Free Cash Flow | $-142.66m |
| Cash position | $412.67m |
Is Summit Therapeutics PLC Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.
Summit Therapeutics PLC Sponsored ADR Stock Analysis
Analyst Opinions
6 Analysts have issued a Summit Therapeutics PLC Sponsored ADR forecast:
Analyst Opinions
6 Analysts have issued a Summit Therapeutics PLC Sponsored ADR forecast:
Financial data from Summit Therapeutics PLC Sponsored ADR
| Dec '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.09 -0.09 |
96%
96%
|
|
| EBITDA | -211 -211 |
141%
141%
|
EBIT (Operating Income) EBIT | -211 -211 |
135%
135%
|
| Net Profit | -221 -221 |
64%
64%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Summit Therapeutics PLC Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Summit Therapeutics PLC Sponsored ADR Stock News
Company Profile
Summit Therapeutics Plc operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company operates through the Drug Development segment, which covers its research and development activities carried out by the Group. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom.
| Head office | United Kingdom |
| CEO | Robert Zanganeh |
| Employees | 159 |
| Founded | 2003 |
| Website | www.smmttx.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
